PREVENTIVE STRATEGIES FOR RECURRENT URINARY TRACT INFECTIONS: THE ROLE OF DIET AND NON-ANTIBIOTIC AGENTS
Abstract
Background: Recurrent urinary tract infections remain a significant clinical and public health concern due to their high prevalence, considerable recurrence rates, and the growing challenge of antimicrobial resistance. In light of the limitations associated with long-term antibiotic use, non-antibiotic prophylactic strategies have garnered increasing interest. This review synthesizes current evidence on the efficacy of various non-antibiotic interventions, including behavioral and dietary modifications, probiotics, cranberry products, D-mannose, methenamine hippurate, topical vaginal estrogen, and immunoprophylaxis.
Aim: This study aims to introduce non-antibiotic approaches to the prevention of recurrent urinary tract infections and to highlight how their integration into clinical practice may decrease reliance on antibiotics and improve long-term patient outcomes.
Methods: This narrative review synthesizes current research findings on the topic. The literature search was conducted using PubMed and Google Scholar database, focusing on recent studies relevant to non-antibiotic strategies for the prevention of recurrent urinary tract infections.
References
Öztürk R, Murt A. Epidemiology of urological infections: a global burden. World J Urol. 2020;38(11):2669-2679. doi:10.1007/s00345-019-03071-4
Car J. Urinary tract infections in women: diagnosis and management in primary care. BMJ. 2006;332(7533):94-97. doi:10.1136/bmj.332.7533.94
Bertoni G, Pessacq P, Guerrini MG, et al. Etiología y resistencia a antimicrobianos de la infección no complicada del tracto urinario [Etiology and antimicrobial resistance of uncomplicated urinary tract infections]. Medicina (B Aires). 2017;77(4):304-308.
Guliciuc M, Porav-Hodade D, Mihailov R, et al. Exploring the Dynamic Role of Bacterial Etiology in Complicated Urinary Tract Infections. Medicina (Kaunas). 2023;59(9):1686. Published 2023 Sep 20. doi:10.3390/medicina59091686
Neal DE Jr. Complicated urinary tract infections. Urol Clin North Am. 2008;35(1):13-v. doi:10.1016/j.ucl.2007.09.010
Besharati F, Rafiee F, Jalalifar S, et al. A systematic review and meta-analysis of urinary tract infection, frequency of IS elements and MDR isolates retrieved from adult patients. Gene Rep. 2021;23:101072. doi:10.1016/j.genrep.2021.101072
Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49(2):53-70. doi:10.1067/mda.2003.7
Aggarwal N, Leslie SW. Recurrent Urinary Tract Infections. In: StatPearls. Treasure Island (FL): StatPearls Publishing; January 20, 2025.
EAU Guidelines. Edn. presented at the EAU Annual Congress Madrid, Spain 2025. ISBN 978-94-92671-29-5
Albert X, Huertas I, Pereiró II, Sanfélix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev. 2004;2004(3):CD001209. doi:10.1002/14651858.CD001209.pub2
Parry CM, Taylor A, Williams R, Lally H, Corbett HJ. Antimicrobial resistance of breakthrough urinary tract infections in young children receiving continual antibiotic prophylaxis. Eur J Pediatr. 2023;182(9):4087-4093. doi:10.1007/s00431-023-05087-w
EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA); Scientific Opinion on Dietary reference values for water. EFSA Journal 2010; 8(3):1459. [48 pp.]. doi:10.2903/j.efsa.2010.1459.
Perrier ET, Armstrong LE, Bottin JH, et al. Hydration for health hypothesis: a narrative review of supporting evidence. Eur J Nutr. 2021;60(3):1167-1180. doi:10.1007/s00394-020-02296-z
Hooton TM, Vecchio M, Iroz A, et al. Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections: A Randomized Clinical Trial. JAMA Intern Med. 2018;178(11):1509-1515. doi:10.1001/jamainternmed.2018.4204
Zemdegs J, Iroz A, Vecchio M, Roze S, Lotan Y. Water intake and recurrent urinary tract infections prevention: economic impact analysis in seven countries. BMC Health Serv Res. 2023;23(1):1197. Published 2023 Nov 3. doi:10.1186/s12913-023-10234-y
Persad S, Watermeyer S, Griffiths A, Cherian B, Evans J. Association between urinary tract infection and postmicturition wiping habit. Acta Obstet Gynecol Scand. 2006;85(11):1395-1396. doi:10.1080/00016340600936977
Akaishi T. Post-Toilet Wiping Style Is Associated With the Risk of Urinary Tract Infection in Women. Cureus. 2024;16(4):e58107. Published 2024 Apr 12. doi:10.7759/cureus.58107
Foxman B, Frerichs RR. Epidemiology of urinary tract infection: I. Diaphragm use and sexual intercourse. Am J Public Health. 1985;75(11):1308-1313. doi:10.2105/ajph.75.11.1308
Elster AB, Lach PA, Roghmann KJ, McAnarney ER. Relationship between frequency of sexual intercourse and urinary tract infections in young women. South Med J. 1981;74(6):704-708. doi:10.1097/00007611-198106000-00018
Foxman B, Frerichs RR. Epidemiology of urinary tract infection: II. Diet, clothing, and urination habits. Am J Public Health. 1985;75(11):1314-1317. doi:10.2105/ajph.75.11.1314
Vyas S, Sharma P, Srivastava K, Nautiyal V, Shrotriya VP. Role of Behavioural Risk Factors in Symptoms Related to UTI Among Nursing Students. J Clin Diagn Res. 2015;9(9):LC15-LC18. doi:10.7860/JCDR/2015/10995.6547
Kontiokari T, Laitinen J, Järvi L, Pokka T, Sundqvist K, Uhari M. Dietary factors protecting women from urinary tract infection. Am J Clin Nutr. 2003;77(3):600-604. doi:10.1093/ajcn/77.3.600
Du Y, Sui X, Bai Y, et al. Dietary influences on urinary tract infections: unraveling the gut microbiota connection. Food Funct. 2024;15(19):10099-10109. Published 2024 Sep 30. doi:10.1039/d4fo03271c
Saraiva A, Raheem D, Roy PR, et al. Probiotics and Plant-Based Foods as Preventive Agents of Urinary Tract Infection: A Narrative Review of Possible Mechanisms Related to Health. Nutrients. 2025;17(6):986. Published 2025 Mar 11. doi:10.3390/nu17060986
Mititelu M, Olteanu G, Neacșu SM, et al. Incidence of Urinary Infections and Behavioral Risk Factors. Nutrients. 2024;16(3):446. Published 2024 Feb 2. doi:10.3390/nu16030446
Nemzer BV, Al-Taher F, Yashin A, Revelsky I, Yashin Y. Cranberry: Chemical Composition, Antioxidant Activity and Impact on Human Health: Overview. Molecules. 2022; 27(5):1503. https://doi.org/10.3390/molecules27051503
Gupta K, Chou MY, Howell A, Wobbe C, Grady R, Stapleton AE. Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol. 2007;177(6):2357-2360. doi:10.1016/j.juro.2007.01.114
Faggian M, Bernabè G, Valente M, et al. Characterization of PACs profile and bioactivity of a novel nutraceutical combining cranberry extracts with different PAC-A oligomers, D-mannose and ascorbic acid: An in vivo/ex vivo evaluation of dual mechanism of action on intestinal barrier and urinary epithelium. Food Res Int. 2021;149:110649. doi:10.1016/j.foodres.2021.110649
Feldman M, Tanabe S, Howell A, Grenier D. Cranberry proanthocyanidins inhibit the adherence properties of Candida albicans and cytokine secretion by oral epithelial cells. BMC Complement Altern Med. 2012;12:6. Published 2012 Jan 16. doi:10.1186/1472-6882-12-6
Ben Lagha A, Howell A, Grenier D. Cranberry Proanthocyanidins Neutralize the Effects of Aggregatibacter actinomycetemcomitans Leukotoxin. Toxins (Basel). 2019;11(11):662. Published 2019 Nov 14. doi:10.3390/toxins11110662
Moro C, Phelps C, Veer V, et al. Cranberry Juice, Cranberry Tablets, or Liquid Therapies for Urinary Tract Infection: A Systematic Review and Network Meta-analysis. Eur Urol Focus. 2024;10(6):947-957. doi:10.1016/j.euf.2024.07.002
Stonehouse W, Benassi-Evans B, Bednarz J, Vincent AD. Whole cranberry fruit powder supplement reduces the incidence of culture-confirmed urinary tract infections in females with a history of recurrent urinary tract infection: A 6-month multicenter, randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2025;121(4):932-941. doi:10.1016/j.ajcnut.2025.01.022
Jepson RG, Mihaljevic L, Craig JC. Cranberries for treating urinary tract infections. Cochrane Database Syst Rev. 2023;12(12):CD001322. Published 2023 Dec 14. doi:10.1002/14651858.CD001322.pub2
American Urological Association. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2022). Accessed at auanet.org/guidelines-and-quality/guidelines/recurrent-utiLink to External Link Policy on September 20, 2023.
Marelli G, Papaleo E, Ferrari A. Lactobacilli for prevention of urogenital infections: a review. Eur Rev Med Pharmacol Sci. 2004;8(2):87-95.
Neugent ML, Hulyalkar NV, Nguyen VH, Zimmern PE, De Nisco NJ. Advances in Understanding the Human Urinary Microbiome and Its Potential Role in Urinary Tract Infection. mBio. 2020;11(2):e00218-20. Published 2020 Apr 28. doi:10.1128/mBio.00218-20
Andreu A, Stapleton AE, Fennell CL, Hillier SL, Stamm WE. Hemagglutination, adherence, and surface properties of vaginal Lactobacillus species. J Infect Dis. 1995;171(5):1237-1243. doi:10.1093/infdis/171.5.1237
Osset J, Bartolomé RM, García E, Andreu A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis. 2001;183(3):485-491. doi:10.1086/318070
Falagas ME, Betsi GI, Tokas T, Athanasiou S. Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs. 2006;66(9):1253-1261. doi:10.2165/00003495-200666090-00007
Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011;52(10):1212-1217. doi:10.1093/cid/cir183
Gupta V, Mastromarino P, Garg R. Effectiveness of Prophylactic Oral and/or Vaginal Probiotic Supplementation in the Prevention of Recurrent Urinary Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Trial. Clin Infect Dis. 2024;78(5):1154-1161. doi:10.1093/cid/ciad766
Abdullatif VA, Sur RL, Eshaghian E, et al. Efficacy of Probiotics as Prophylaxis for Urinary Tract Infections in Premenopausal Women: A Systematic Review and Meta-Analysis. Cureus. 2021;13(10):e18843. Published 2021 Oct 17. doi:10.7759/cureus.18843
Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev. 2015;2015(12):CD008772. Published 2015 Dec 23. doi:10.1002/14651858.CD008772.pub2
Smith AL, Brown J, Wyman JF, Berry A, Newman DK, Stapleton AE. Treatment and Prevention of Recurrent Lower Urinary Tract Infections in Women: A Rapid Review with Practice Recommendations. J Urol. 2018;200(6):1174-1191. doi:10.1016/j.juro.2018.04.088
Hu X, Shi Y, Zhang P, Miao M, Zhang T, Jiang B. d-Mannose: Properties, Production, and Applications: An Overview. Compr Rev Food Sci Food Saf. 2016;15(4):773-785. doi:10.1111/1541-4337.12211
Schaeffer AJ, Amundsen SK, Jones JM. Effect of carbohydrates on adherence of Escherichica coli to human urinary tract epithelial cells. Infect Immun. 1980;30(2):531-537. doi:10.1128/iai.30.2.531-537.1980
Wagenlehner F, Lorenz H, Ewald O, Gerke P. Why d-Mannose May Be as Efficient as Antibiotics in the Treatment of Acute Uncomplicated Lower Urinary Tract Infections-Preliminary Considerations and Conclusions from a Non-Interventional Study. Antibiotics (Basel). 2022;11(3):314. Published 2022 Feb 25. doi:10.3390/antibiotics11030314
Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32(1):79-84. doi:10.1007/s00345-013-1091-6
Salvatore S, Ruffolo AF, Stabile G, Casiraghi A, Zito G, De Seta F. A Randomized Controlled Trial Comparing a New D-Mannose-based Dietary Supplement to Placebo for the Treatment of Uncomplicated Escherichia coli Urinary Tract Infections. Eur Urol Focus. 2023;9(4):654-659. doi:10.1016/j.euf.2022.12.013
Hayward G, Mort S, Hay AD, et al. d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial. JAMA Intern Med. 2024;184(6):619-628. doi:10.1001/jamainternmed.2024.0264
Cooper TE, Teng C, Howell M, Teixeira-Pinto A, Jaure A, Wong G. D-mannose for preventing and treating urinary tract infections. Cochrane Database Syst Rev. 2022;8(8):CD013608. Published 2022 Aug 30. doi:10.1002/14651858.CD013608.pub2
Lo TS, Hammer KD, Zegarra M, Cho WC. Methenamine: a forgotten drug for preventing recurrent urinary tract infection in a multidrug resistance era. Expert Rev Anti Infect Ther. 2014;12(5):549-554. doi:10.1586/14787210.2014.904202
Lee BS, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10(10):CD003265. Published 2012 Oct 17. doi:10.1002/14651858.CD003265.pub3
Bakhit M, Krzyzaniak N, Hilder J, Clark J, Scott AM, Mar CD. Use of methenamine hippurate to prevent urinary tract infections in community adult women: a systematic review and meta-analysis. Br J Gen Pract. 2021;71(708):e528-e537. Published 2021 Jun 24. doi:10.3399/BJGP.2020.0833
Hollyer I, Varias F, Ho B, Ison MG. Safety and efficacy of methenamine hippurate for the prevention of recurrent urinary tract infections in adult renal transplant recipients: A single center, retrospective study. Transpl Infect Dis. 2019;21(3):e13063. doi:10.1111/tid.13063
Hobaica NC, De Oliveira GC, Porto BC, et al. Effectiveness of methenamine hippurate in preventing urinary tract infections: an updated systematic review, meta-analysis and trial sequential analysis of randomized controlled trials. BMC Urol. 2025;25(1):30. Published 2025 Feb 15. doi:10.1186/s12894-025-01708-8
Silva C, Rey R, Elena Nader-Macías M. Effects of estrogen administration on the colonization capability of lactobacilli and Escherichia coli in the urinary tracts of mice. Methods Mol Biol. 2004;268:387-399. doi:10.1385/1-59259-766-1:387
Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016;91:42-50. doi:10.1016/j.maturitas.2016.05.015
Farage, M.A., Miller, K.W., Song, Y., Sobel, J. (2017). The Vaginal Microbiota in Menopause. In: Farage, M., Miller, K., Maibach, H. (eds) Textbook of Aging Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47398-6_84
Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008;(2):CD005131. Published 2008 Apr 16. doi:10.1002/14651858.CD005131.pub2
Chen YY, Su TH, Lau HH. Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials. Int Urogynecol J. 2021;32(1):17-25. doi:10.1007/s00192-020-04397-z
Houston CG, Azar WS, Huang SS, Rubin R, Dorris CS, Sussman RD. A Cost Savings Analysis of Topical Estrogen Therapy in Urinary Tract Infection Prevention Among Postmenopausal Women. Urol Pract. 2024;11(2):257-266. doi:10.1097/UPJ.0000000000000513
Bessler WG, Puce K, vor dem Esche U, Kirschning C, Huber M. Immunomodulating effects of OM-89, a bacterial extract from Escherichia coli, in murine and human leukocytes. Arzneimittelforschung. 2009;59(11):571-577. doi:10.1055/s-0031-1296446
Brodie A, El-Taji O, Jour I, Foley C, Hanbury D. A Retrospective Study of Immunotherapy Treatment with Uro-Vaxom (OM-89®) for Prophylaxis of Recurrent Urinary Tract Infections. Curr Urol. 2020;14(3):130-134. doi:10.1159/000499248
Prattley S, Geraghty R, Moore M, Somani BK. Role of Vaccines for Recurrent Urinary Tract Infections: A Systematic Review. Eur Urol Focus. 2020;6(3):593-604. doi:10.1016/j.euf.2019.11.002
Nestler S, Grüne B, Schilchegger L, Suna A, Perez A, Neisius A. Efficacy of vaccination with StroVac for recurrent urinary tract infections in women: a comparative single-centre study. Int Urol Nephrol. 2021;53(11):2267-2272. doi:10.1007/s11255-021-02987-4
Copyright (c) 2025 Martyna Różańska, Bartłomiej Kusy, Agnieszka Bajkacz, Karolina Niewola, Michał Robak, Marcin Płonka, Maciej Dudziński, Hanna Ćwirko
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
